Anatomic Stage IIIA Breast Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04001829Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerSupportive Care